重大事件
即時報告
8-K
2026-06-10
Prelude Therapeutics 提交 8-K 文件 股東投票結果待查閱
AI 繁中摘要
Prelude Therapeutics Inc（製藥公司）提交了一份 8-K 申報文件（報告日期：2026 年 6 月 9 日），主要涉及股東投票事項（Item 5.07）。是次申報未在摘要中披露具體投票結果或議案細節，投資者應查閱完整文件以了解股東大會通過的決議及投票比例。📄
由於該公司為生物製藥領域，此類投票可能與董事選舉、高管薪酬或重大交易相關，或對公司管治及未來策略有影響。建議投資者關注後續披露，以評估潛在股權結構變化或管理層穩定性。🔍
展開英文正文
EDGAR Filing Documents for 0001193125-26-265835 SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form 8-K - Current report: SEC Accession No. 0001193125-26-265835 Filing Date 2026-06-10 Accepted 2026-06-10 16:11:13 Documents 9 Period of Report 2026-06-09 Items Item 5.07: Submission of Matters to a Vote of Security Holders Interactive Data Document Format Files Seq Description Document Type Size 1 8-K prld-20260609.htm iXBRL 8-K 77650 Complete submission text file 0001193125-26-265835.txt 207154 Data Files Seq Description Document Type Size 2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT prld-20260609.xsd EX-101.SCH 45171 12 EXTRACTED XBRL INSTANCE DOCUMENT prld-20260609_htm.xml XML 4543 Mailing Address 175 INNOVATION BOULEVARD WILMINGTON DE 19805 Business Address 175 INNOVATION BOULEVARD WILMINGTON DE 19805 (302) 467-1280 Prelude Therapeutics Inc (Filer) CIK: 0001678660 (see all company filings) EIN.: 811384762 | State of Incorp.: DE | Fiscal Year End: 1231 Type: 8-K | Act: 34 | File No.: 001-39527 | Film No.: 261079773 SIC: 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)